Overview
Rijwan Ahammad practices practicing medicine in Nagoya, Japan.
Ahammad is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Guillain-Barre Syndrome, ADULT Syndrome, and Dementia.
They are actively involved in clinical research, co-authoring 17 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rijwan U. Ahammad
Is Rijwan U. Ahammad a top-rated expert for Guillain-Barre Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Rijwan U. Ahammad is classified as an Advanced expert for Guillain-Barre Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rijwan U. Ahammad participate in research or clinical trials?
Yes. Rijwan U. Ahammad has published 17 articles and abstracts on conditions like Guillain-Barre Syndrome. You can view a list of Rijwan U. Ahammad's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Guillain-Barre SyndromeAhammad isAdvanced. Learn about Guillain-Barre Syndrome.
- Experienced
- ADULT SyndromeAhammad isExperienced. Learn about ADULT Syndrome.
- DementiaAhammad isExperienced. Learn about Dementia.